Zosano Pharma Corporation (ZSAN) Stock Price Down 1.4%

Zosano Pharma Corporation (NASDAQ:ZSAN) shares dropped 1.4% on Tuesday . The company traded as low as $0.57 and last traded at $0.68. Approximately 393,200 shares changed hands during mid-day trading, a decline of 75% from the average daily volume of 1,570,178 shares. The stock had previously closed at $0.69.

Separately, ValuEngine raised shares of Zosano Pharma Corporation from a “strong sell” rating to a “sell” rating in a report on Friday, September 1st.

Zosano Pharma Corporation (NASDAQ:ZSAN) last released its quarterly earnings data on Thursday, November 9th. The biotechnology company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.15) by ($0.05). research analysts anticipate that Zosano Pharma Corporation will post -0.79 EPS for the current year.

A hedge fund recently raised its stake in Zosano Pharma Corporation stock. Northern Trust Corp lifted its stake in shares of Zosano Pharma Corporation (NASDAQ:ZSAN) by 591.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 79,234 shares of the biotechnology company’s stock after purchasing an additional 67,774 shares during the period. Northern Trust Corp owned about 0.20% of Zosano Pharma Corporation worth $112,000 as of its most recent filing with the Securities & Exchange Commission. 22.67% of the stock is owned by institutional investors and hedge funds.

WARNING: This news story was originally published by Transcript Daily and is owned by of Transcript Daily. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://transcriptdaily.com/2017/11/15/zosano-pharma-corporation-zsan-stock-price-down-1-4.html.

About Zosano Pharma Corporation

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability.

Receive News & Ratings for Zosano Pharma Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zosano Pharma Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply